HealthcareServices

Global Cell Based Assays Market 2026–2030: Forecast Insights for Business Planning

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cell based assays market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Cell Based Assays Market?

The cell based assays market has demonstrated significant expansion in recent years. Its size is projected to increase from $29.41 billion in 2025 to $33.21 billion in 2026, advancing at a compound annual growth rate (CAGR) of 12.9%. Historically, this growth has been fueled by increasing drug discovery activities, the expansion of in vitro research methodologies, a rising utilization of cell-based models in basic research, the availability of advanced assay consumables, and an increase in pharmaceutical R&D spending.

The cell based assays market is anticipated to experience substantial growth in the next few years. It is forecast to reach $54.79 billion by 2030, expanding at a compound annual growth rate (CAGR) of 13.3%. This expansion during the forecast period is attributed to the increasing adoption of AI-assisted assay analysis, rising demand for complex disease modeling, the growth of personalized medicine research, the expanding use of automation in laboratories, and increasing investments in advanced screening platforms. Major trends expected in this period include the wider adoption of high-throughput cell-based screening, a rising use of automated cell handling systems, a growing demand for predictive toxicology assays, the expansion of label-free cell analysis methods, and an enhanced focus on physiologically relevant cell models.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2546&type=smp

Which Drivers Are Supporting The Rise Of The Cell Based Assays Market?

Growth in biologics revenue is projected to drive the cell-based assays market. Biologics, or biological products, refer to medicines derived from living organisms, including a variety of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Cell-based assays are essential in biologics for evaluating their functionality, potency, safety, and bio-similarity. For instance, in October 2024, according to the Generics and Biosimilars Initiative, a Belgium-based organization that provides high-quality, scientific information on generic and biosimilar medicines, two additional complex drugs recorded significant sales in 2023, beyond the nine leading biologics. Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both prescribed for type 2 diabetes, achieved sales of US$14 billion and US$7.2 billion, respectively. Consequently, the increase in electronic payment methods is propelling the cell-based assays market.

What Segments Are Identified Within The Structure Of The Cell Based Assays Market?

The cell based assays market covered in this report is segmented –

1) By Product And Service: Consumables, Instruments, Services, Software

2) By Technology: Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies

3) By Application: Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users

Subsegments:

1) By Consumables: Cell Culture Media, Reagents And Kits, Cell Lines, Microplates

2) By Instruments: Microplate Readers, Flow Cytometers, Cell Imaging Systems, Automated Cell Culture Systems

3) By Services: Custom Assay Development, Contract Research Services

4) By Software: Data Analysis Software, Lab Management Software, Simulation And Modeling Software

Which Competitive Trends Are Impacting The Structure Of The Cell Based Assays Market?

Key companies operating in the cell-based assays market are introducing new platforms, like cell-based phenotypic assay platforms, to deliver sophisticated solutions for drug discovery. A cell-based phenotypic assay platform is a system employed in drug discovery that assesses cellular responses to compound treatments through the integration of advanced imaging and analytical tools, enhanced by artificial intelligence. For example, in June 2024, Sphere Fluidics, a UK-based life sciences R&D company, launched Cyto-Cellect PLUS. Cyto-Cellect PLUS is an accessible Fluorescence Resonance Energy Transfer (FRET) assay designed to allow researchers to precisely measure IgG productivity with high sensitivity. Building on Sphere Fluidics’ original Cyto-Cellect Human IgG? Detection Kit, this enhanced version additionally detects both IgG ? and ? light chains, broadening its application. The assay is fully compatible with existing Cyto-Mine® functionality, enabling single-cell dispensing into 96-well and 384-well plates. Moreover, it adheres to relevant regulatory standards by being free of animal origins, making it simple to incorporate into current cell line development processes.

Which Key Players Are Driving Competition In The Cell Based Assays Market?

Major companies operating in the cell based assays market are Promega Corporation, Bio-Rad Laboratories Inc, PerkinElmer Inc, Abcam plc, Enzo Life Sciences Inc, Cell Signaling Technology Inc, Cisbio International LLC, Eurofins Scientific SE, Charles River Laboratories International Inc, Miltenyi Biotec GmbH, Lonza Group Ltd, Corning Incorporated, Becton Dickinson and Company, Danaher Corporation, GE HealthCare Technologies Inc, BioVision Inc, Biotium Inc, ProQinase GmbH, QGel SA, Cell Biolabs Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Which Region Is Projected To Lead The Cell Based Assays Market During The Forecast Period?

North America was the largest region in the cell-based assays market in 2025. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in the cell based assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell Based Assays Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2546&type=smp

Browse Through More Reports Similar to the Global Cell Based Assays Market 2026, By The Business Research Company

Cell Cultures Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Cell Viability Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Stem Cell Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795